Literature DB >> 24025680

Regulation of neuropeptide Y Y1 receptor expression by bone morphogenetic protein 2 in C2C12 myoblasts.

Naoko Kurebayashi1, Mari Sato, Toshiaki Fujisawa, Kazuaki Fukushima, Masato Tamura.   

Abstract

The neuropeptide Y (NPY) system is known as one of the major neural signaling pathways. NPY, produced by peripheral tissues including osteoblasts, is known to bind to the Y1 receptor. Recently, osteoblast-specific Y1 receptor knockout mice were developed and were found to have a high bone mass phenotype, indicating a role for the NPY-Y1 receptor axis as a regulator of bone homeostasis. However, regulation of Y1 receptor expression during osteoblastic differentiation remains unexplored. In the present study, we examined the role of bone morphogenetic protein (BMP) 2 signaling in regulating Y1 receptor expression. In C2C12 cells, expression of Y1 receptor mRNA was induced by BMP2. This induction was also observed after co-transfection with Smad1 and Smad4, the intracellular signaling molecules of the BMP2 signaling pathway. In a transfection assay, Smad1/4 up-regulated transcriptional activity through interaction with the Y1 receptor gene promoter. Following transfection of MC3T3-E1 cells with siRNA for the Y1 receptor, the expression of alkaline phosphatase, osteocalcin, Runx2 and osterix were increased. These results show that BMP2 signaling regulates Y1 receptor gene expression, and raises the possibility that NPY acts in osteoblasts via an autocrine mechanism.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone morphogenetic protein 2; Neuropeptide Y; Osteoblasts; Y1 receptor

Mesh:

Substances:

Year:  2013        PMID: 24025680     DOI: 10.1016/j.bbrc.2013.09.014

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.

Authors:  F-S Wang; W-S Lian; W-T Weng; Y-C Sun; H-J Ke; Y-S Chen; J-Y Ko
Journal:  Osteoporos Int       Date:  2016-04-14       Impact factor: 4.507

2.  [Neuropeptide Y Y1 receptor antagonist PD160170 promotes osteogenic differentiation of rat bone marrow mesenchymal stem cells in vitro and femoral defect repair in rats].

Authors:  Song Liu; Jian-Qun Wu; Ji-Jie Hu; Le Wang; Zhao Wang; Huan Meng; Ling-Jian Zhuo; Jian-Xiong Zheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

3.  Neuropeptide Y, substance P, and human bone morphogenetic protein 2 stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular communication.

Authors:  W H Ma; Y J Liu; W Wang; Y Z Zhang
Journal:  Braz J Med Biol Res       Date:  2015-02-13       Impact factor: 2.590

4.  Integrative Analysis of Exosomal miR-452 and miR-4713 Downregulating NPY1R for the Prevention of Childhood Obesity.

Authors:  Xiaoyan Feng; Ye Ding; Min Zhou; Na Song; Yanhong Ding
Journal:  Dis Markers       Date:  2022-03-30       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.